ResearcherTufts UniversityActive in the last 2 years
Hassan Aziz
Matched on ORCID iD 0000-0003-0406-1946; OpenAlex author ID A5038697227. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 1, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 12
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 2 papers · 2025: 1 paper · 2026: 2 papers
Papers 9
- Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.1002/jso.70329↗
- Factors associated with mortality in pancreatic adenocarcinoma patients achieving pathologic complete response after neoadjuvant therapy. Co-author DOI 10.1016/j.amjsurg.2026.117093↗
- Association Between Psychiatric Illness and Short-Term Outcomes Among Patients With Hepatobiliary and Pancreatic Cancer. Co-author DOI 10.1016/j.jss.2025.03.010↗
- Comparative outcomes of treatment modalities in nonagenarians with nonmetastatic pancreatic adenocarcinoma. Last author DOI 10.1016/j.gassur.2024.06.007↗
- Patterns of care and outcomes for hepatocellular carcinoma and pancreatic cancer based on rurality of patient's residence in a rural midwestern state. Last author DOI 10.1016/j.gassur.2024.09.013↗
- Does Extended Lymphadenectomy Help in Pancreatic Cancer? Co-author DOI 10.1245/s10434-022-11370-1↗
- Comment on: "Impact of Tumor Size on the Outcomes of Patients with Resectable Distal Pancreatic Cancer". First author DOI 10.1245/s10434-022-11840-6↗
- Survival Benefits and Disparities in Adjuvant Radiation Therapy for Patients with Pancreatic Cancer. Last author PMID 34354555↗
- Neoadjuvant Chemoradiation Therapy Is Associated with Adverse Outcomes in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Cancer. Co-author DOI 10.1177/000313481908501136↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mohammed O. Suraju · 4 shared papers, 2024–2026 · strength 1.02
- Paper Impact of Neoadjuvant Approach and Tumor Response on Survival in Pancreatic Adenocarcinoma. DOI 10.1002/jso.70329↗
- Paper Factors associated with mortality in pancreatic adenocarcinoma patients achieving pathologic complete response after ne… DOI 10.1016/j.amjsurg.2026.117093↗
- Paper Comparative outcomes of treatment modalities in nonagenarians with nonmetastatic pancreatic adenocarcinoma. DOI 10.1016/j.gassur.2024.06.007↗
- Carlos H.F. Chan · 2 shared papers, 2026 · strength 0.57
- Faisal Jehan · 2 shared papers, 2024–2025 · strength 0.52
- Paper Association Between Psychiatric Illness and Short-Term Outcomes Among Patients With Hepatobiliary and Pancreatic Cancer. DOI 10.1016/j.jss.2025.03.010↗
- Paper Comparative outcomes of treatment modalities in nonagenarians with nonmetastatic pancreatic adenocarcinoma. DOI 10.1016/j.gassur.2024.06.007↗
- Timothy Michael Pawlik · 2 shared papers, 2022 · strength 0.49
- Mohammad R. Khreiss · 1 shared paper, 2025 · strength 0.28
- Daniel Brock Hewitt · 1 shared paper, 2022 · strength 0.26
- Shahzaib Ahmad · 1 shared paper, 2024 · strength 0.24
- Gaya Spolverato · 1 shared paper, 2022 · strength 0.22
- Jordan M. Cloyd · 1 shared paper, 2022 · strength 0.22
- Mirza Zain Baig · 1 shared paper, 2021 · strength 0.17
- Muhammad Wasif Saif · 1 shared paper, 2021 · strength 0.17
- Felipe B. Maegawa · 1 shared paper, 2019 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.